Literature DB >> 22809270

Indications for portal pressure measurement in chronic liver disease.

Lise Hobolth1, Flemming Bendtsen, Søren Møller.   

Abstract

Portal hypertension leads to development of serious complications such as esophageal varices, ascites, renal and cardiovascular dysfunction. The importance of the degree of portal hypertension has been substantiated within recent years. Measurement of the portal pressure is simple and safe and the hepatic venous pressure gradient (HVPG) independently predicts survival and development of complications such as ascites, HCC and bleeding from esophageal varices. Moreover, measurements of HVPG can be used to guide pharmacotherapy for primary and secondary prophylaxis for variceal bleeding. Assessment of HVPG should therefore be considered as a part of the general characterization of patients with portal hypertension in departments assessing and treating this condition.

Entities:  

Mesh:

Year:  2012        PMID: 22809270     DOI: 10.3109/00365521.2012.706827

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives.

Authors:  Beom Kyung Kim; James Fung; Man-Fung Yuen; Seung Up Kim
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

2.  Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?

Authors:  Puria Nabilou; Karen Vagner Danielsen; Nina Kimer; Jens Dahlgaard Hove; Flemming Bendtsen; Søren Møller
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

3.  Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis.

Authors:  Gai-Qin Li; Bo Yang; Jun Liu; Guang-Chuan Wang; Hai-Peng Yuan; Jing-Run Zhao; Ji-Yong Liu; Xiao-Pei Li; Chun-Qing Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Risk Factors for Intractable Ascites After Adult-to-Adult Living Donor Liver Transplantation Using Left Lobe.

Authors:  Shinichi Matsudaira; Yoichi Ishizaki; Jiro Yoshimoto; Noriko Fujiwara; Seiji Kawasaki
Journal:  Transplant Direct       Date:  2017-02-16

5.  Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.

Authors:  Emilie Garnæs; Christian Mortensen; Lise Hobolth; Ove Andersen; Jan Nehlin; Søren Møller
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

6.  Usefulness of Venous Pressure Measurement in Endovascular Treatment of Budd-Chiari Syndrome: A Retrospective Cohort Study.

Authors:  Ken Kageyama; Akira Yamamoto; Atsushi Jogo; Takehito Nota; Kazuki Murai; Satoyuki Ogawa; Mariko M Nakano; Etsuji Sohgawa; Shinichi Hamamoto; Masao Hamuro; Toshio Kaminou; Norifumi Nishida; Kanae Takahashi; Kouji Yamamoto; Yukio Miki
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.